Stocks
Teva Pharmaceutical Industries (TEVA) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 37.4 | 9.72 | 13.9 | 33.3 | 31.2 | 35.5 | |||
| Changes by years, y/y, % | +126% | -74% | +43% | +140% | -6% | +13.5% | |||
Teva Pharmaceutical Industries. P/FCF
Teva Pharmaceutical Industries. P/FCF, changes, %
Teva Pharmaceutical Industries (TEVA) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | 22.9 | 21.6 | 40.1 | 31.2 | 29.7 | 35.5 | ||
| Changes by years, y/y, % | +27% | -20% | +169% | -6% | +30% | |||
| Changes by quarters, q/q, % | -31% | -6% | +86% | -22% | -5% | |||
